Trials / Unknown
UnknownNCT02930616
A Comparison of pCLE Based Targeted Biopsy and WLE Based Standard Biopsy in Staging the Operative Link on Gastric Intestinal Metaplasia (OLGIM): A Randomized，Cross-over Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Gastric intestinal metaplasia (GIM) is an important premalignant lesion for gastric cancer. Precisely surveillance of patients with GIM may result in early detection and improved prognosis. Though important, it is not necessary to recommend surveillance endoscopy for all patients with GIM, since the progression rate to gastric cancer within 10 years is only 1.8% in those patients.
Conditions
- Gastric Intestinal Metaplasia
- Confocal Laser Endomicroscopy
- Operative Link on Gastric Intestinal Metaplasia
- Biopsy
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Patients in Group 1 will receive pCLE at first and WLE 2 months later | |
| DEVICE | patients in Group 2 will receive WLE at first and pCLE 2 months later. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2016-10-12
- Last updated
- 2016-10-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02930616. Inclusion in this directory is not an endorsement.